D. Niederwieser

发表

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

G. Schuler, N. Romani, D. Reider, 1997, Advances in experimental medicine and biology.

Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens

S. Gaggl, M. Herold, D. Niederwieser, 1993 .

Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.

D. Niederwieser, C. Huber, S. Gaggl, 1993, Blood.

Aspergillosis in acute myelogenous leukemia.

D. Niederwieser, D. Nachbaur, D. zur Nedden, 1996, International archives of allergy and immunology.

Effective T cell regeneration following high-dose chemotherapy rescued with CD34+ cell enriched peripheral blood progenitor cells in children

D. Niederwieser, D. Nachbaur, F. Fink, 1999, Bone Marrow Transplantation.

Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment

W. Fleischhacker, D. Niederwieser, B. Holzner, 1998, Annals of Hematology.

Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms’ tumor

D. Niederwieser, H. Schwaighofer, F. Fink, 1997, Bone Marrow Transplantation.

Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation.

D. Niederwieser, C. Ludescher, D. Nachbaur, 2000, Journal of hematotherapy & stem cell research.

Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer.

C. Marth, B. Eibl, D. Niederwieser, 1996, Blood.

CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo.

H. Tilg, O. Majdic, H. Stockinger, 1996, Immunobiology.

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

G. Mufti, S. Iacobelli, J. Sierra, 2006, Blood.

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe.

P. Pedrazzoli, D. Blaise, D. Niederwieser, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation.

D. Niederwieser, H. Greinix, C. Mannhalter, 2000, Transplantation.

CD34+-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experience

D. Niederwieser, C. Ludescher, D. Nachbaur, 1997, Bone Marrow Transplantation.

EORTC QLQ‐C30 and FACT‐BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison

W. Fleischhacker, G. Kemmler, D. Niederwieser, 2000, European journal of haematology.

Successful treatment of primary extramedullary leukemia (EML) of the uterus with radical surgery, chemotherapy, autologous bone marrow transplantation (BMT) and prophylactic local irradiation.

D. Niederwieser, D. Nachbaur, H. Schwaighofer, 1996, Bone marrow transplantation.

Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation.

D. Niederwieser, H. Greinix, D. Niederwieser, 1997, Blood.

Kidney Transplant from the Same Donor without Maintenance Immunosuppression after Previous Hematopoietic Stem Cell Transplant

U. Sack, T. Lindner, D. Niederwieser, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Modulation of alloimmune response in vitro by an IgM‐enriched immunoglobulin preparation (Pentaglobin)

M. Herold, D. Niederwieser, D. Nachbaur, 1998, Immunology.

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

S. Iacobelli, J. Finke, P. Ljungman, 2010, Bone Marrow Transplantation.

Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution.

M. Herold, B. Eibl, D. Niederwieser, 1996, Transplantation.

Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy.

H. Tilg, H. Einsele, D. Niederwieser, 1997, Transplantation.

Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2

F. Allerberger, D. Niederwieser, D. Nachbaur, 1997, Bone Marrow Transplantation.

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation

J Hermans, G. Gahrton, A. Gratwohl, 1998, The Lancet.

Cytokine serum levels during treatment with high-dose recombinant human IL-3 in a patient with severe aplastic anemia

A. Gratwohl, A. Tichelli, M. Herold, 1993, Annals of Hematology.

Transfusion of donor‐type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility

A. Gratwohl, D. Niederwieser, D. Nachbaur, 1995, Transfusion.

Successful second transplant from an HLA-identical unrelated donor after graft rejection in a patient with chronic myelogenous leukemia.

F. Fend, D. Niederwieser, D. Nachbaur, 1994, Transplantation.

A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.

R. Hawliczek, P. Höcker, H. Gadner, 1997, Klinische Padiatrie.

Graft-versus-host disease after autologous bone marrow transplantation: a realistic expectation?

B. Eibl, D. Niederwieser, D. Nachbaur, 1995, Wiener medizinische Wochenschrift.

T‐cell precursor frequencies and long‐term outcome following unrelated hematopoietic stem cell transplantation

H. Greinix, D. Niederwieser, G. Gastl, 2007, International journal of laboratory hematology.

Peripheral blood stem cell (PBSC) collection in extremely low-weight infants.

T. Trieb, P. Höcker, D. Niederwieser, 1996, Bone marrow transplantation.

Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation

A. Gratwohl, D. Niederwieser, J. Hermans, 2001, Leukemia.

Isolated HLA-C mismatches in unrelated donor transplantation for CML

N. Kröger, A. Zander, A. Gratwohl, 2004, Bone Marrow Transplantation.

HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML)

J. Falkenburg, R. Willemze, A. Gratwohl, 2000, Leukemia.

Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial

M. Beksac, H. Goldschmidt, N. Kröger, 2015, Bone Marrow Transplantation.

Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AML

D. Niederwieser, D. Nachbaur, H. Schwaighofer, 1997, Bone Marrow Transplantation.

A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab′)2 fragments (5S IVIG) and Fc fragments. Evidence for post‐transcriptional IL‐2 modulation

C. Huber, M. Herold, B. Eibl, 1997, Immunology.

Nonmyeloablative hematopoietic stem cell transplantation

M. Maris, R. Storb, B. Sandmaier, 2001 .

Role of Lymphokines in the Induction of Graft-Versus-Host Disease

R. Margreiter, D. Niederwieser, C. Huber, 1985 .

Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.

M. Sorror, R. Storb, F. Baron, 2005 .

Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)

A. Gratwohl, M. Aljurf, J. Szer, 2013, Bone Marrow Transplantation.

Serum levels of interleukin 6, interleukin 8, and C-reactive protein after human allogeneic bone marrow transplantation.

H. Tilg, M. Ceska, M. Herold, 1994, Transplantation.

Dose intensive therapy in breast cancer.

C. Gisselbrecht, P. Ljungman, D. Niederwieser, 1992, Bone marrow transplantation.